5-amino-1mq and cd38 inhibitor combination benefits A systems-approach to NAD+ restoration Reduced calorie diet combined with

The optimal time for AOD-9604 administration is in a completely fasted state, typically first thing in the morning upon waking after an overnight fast of 8-10 hours

Energy balance and metabolic control through methylation pathways

Health status considerations: Generally healthy adults with physician clearance, individuals without contraindications (pregnancy, active malignancy, severe organ disease), those willing to commit to proper administration protocols and monitoring, and patients who understand the research-purposes-only status and informed consent requirements

Tirzepatide delivers dramatically more weight loss, has FDA approval, and continues to accumulate positive long-term data across multiple large-scale trials